Section 16. Update on experience in paired-exchange donors in living donor liver transplantation for adult patients at ASAN Medical Center

Transplantation. 2014 Apr 27:97 Suppl 8:S66-9. doi: 10.1097/01.tp.0000446280.81922.bb.

Abstract

Background: An exchange living donor program for liver transplantation, similar to the exchange living donor kidney program, was proposed to avoid ABO-incompatible adult living donor liver transplantation (LDLT). The objective of this study was to present updated changes in exchange adult LDLT program at our institution.

Methods: Between January 2003 and December 2011, approximately 2,182 adult LDLT cases were included in this study. During this period, 26 paired-exchange donor LDLT cases were performed (1.2%).

Results: Of the 26 paired-exchange donor LDLT cases, 22 pairs were matched due to ABO-incompatibility, and 4 pairs were matched because of cascade allocation of unrelated donors or relatively small graft volume to the recipients. A total of 28 living donors were included in the 26 paired-exchange donor LDLT cases because of inclusion of two dual-graft transplants. Elective surgery was performed in 22 cases, and urgent operation was performed in 4 cases. The overall 1-year and 5-year patient and graft survivals were both 96.2% and 90.1%, respectively.

Conclusions: Our experience suggests that the paired-exchange donor program for adult LDLT seems to be a feasible modality to overcome donor ABO incompatibility. Reasonably acceptable indications for donor exchange LDLT will be proposed in near future.

MeSH terms

  • ABO Blood-Group System / immunology*
  • Adult
  • Donor Selection
  • Female
  • Graft Rejection / immunology
  • Graft Rejection / prevention & control
  • Graft Survival
  • Histocompatibility Testing
  • Histocompatibility*
  • Humans
  • Kaplan-Meier Estimate
  • Liver Transplantation / adverse effects
  • Liver Transplantation / methods*
  • Liver Transplantation / mortality
  • Living Donors*
  • Male
  • Middle Aged
  • Program Evaluation
  • Republic of Korea
  • Time Factors
  • Treatment Outcome
  • Young Adult

Substances

  • ABO Blood-Group System